The effect on clinical outcome of glutamine supplementation of parenteral nutrition in the surgical newborn infant

ISRCTN ISRCTN83168963
DOI https://doi.org/10.1186/ISRCTN83168963
Protocol serial number SP3763
Sponsor Action Medical Research (UK)
Funder Action Medical Research (UK)
Submission date
30/04/2003
Registration date
30/04/2003
Last edited
09/10/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Agostino Pierro
Scientific

Paediatric Surgery Unit
Institute of Child Health
30 Guilford Street
London
WC1N 1EH
United Kingdom

Phone +44 (0)20 7272 2814
Email SIGN.Trial@ich.ucl.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study acronymSIGN (Surgical Infants Glutamine Nutrition)
Study objectivesWe will test the hypothesis that glutamine supplementation in the parenteral nutrition (PN) of surgical infants determines more rapid recovery of intestinal function and reduction in infection rate.
Ethics approval(s)Ethics approval received from local medical ethics committee (ref: 2/4/002).
Health condition(s) or problem(s) studiedSurgical newborn infants on parenteral nutrition
InterventionThe treatment group will receive glutamine-supplemented parenteral nutrition.
The control group will receive isonitrogenous parenteral nutrition.

All patients will have data collected once a week on clinical state, feeding, liver and renal function tests, ammonia, septic episodes and parenteral nutrition lines
Intervention typeSupplement
Primary outcome measure(s)

1. Infection: episodes of sepsis and septicaemia, timing of sepsis and septicaemia
2. Intestinal function: time to full enteral feeding and time on (days)

Key secondary outcome measure(s)

1. Growth
2. Nutrient intake
3. Biochemical measures of hepatic function

Completion date30/09/2004

Eligibility

Participant type(s)Patient
Age groupChild
SexAll
Target sample size at registration250
Key inclusion criteria1. Surgical infants below the age of 3 months, either sex
2. Require parenteral nutrition
3. Have received less than 5 days of parenteral nutrition already
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/04/2002
Date of final enrolment30/09/2004

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Paediatric Surgery Unit
London
WC1N 1EH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summary
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes